Keywords
HPLC-ESI-MS/MS
bioequivalência
plasma
farmacocinética
How to Cite
Abstract
A simple, sensitive and specific HPLC/MS/MS methodology was developed and it was validated for determining 3-O-methyldopa, the major metabolite of dopamine, in human plasma. The separation was achieved on Atlantis T3 C18 analytical column (5 μm; 150 x 4.6 mm i.d.) using a mobile phase consisted of a solution of water and methanol (85:15, v/v) and containing formic acid 0.05 %. The extraction from the analyte and the internal standard sample was performed using a simple protein plasma precipitation with perchloric acid. The detection was conducted on a triple quadrupole tandem mass spectrometer with a positive multiple reaction monitoring mode (MRM). The monitored fragmentation transitions were m/z 212.0 m/z 166.0 for 3-O-methyldopa and m/z 227.10 m/z 181.0 for carbidopa (internal standard). The calibration curves were linear in the range of 50–4000 ng/mL for 3-O-methyldopa. The methodology presented a good precision and accuracy in accordance to the criteria for biomedical analysis. And it was successfully applied to the bioequivalence study of two formulations levodopa + benserazide (200 + 50 mg) in plasma samples from healthy human volunteers, following the ANVISA guidelines.References
1. Bugamelli F, Marcheselli C, Barba E, Raggi MA. Determination of L-dopa, carbidopa, 3-O-methyldopa and entacapone in human plasma by HPLC-ED. J Pharm Biomed Anal.2011;54(3):562-7.
2. Galvan A, Wichmann T. Pathophysiology of parkinsonism. Clin Neurophysiol.2008;119(7):1459-74.
3. Keller GA, Czerniuk P, Bertuola R, Spatz JG, Assefi AR, Di Girolamo G. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study. Clin Ther.2011;33(4):500-10.
4. Ensafi A-A, Arabzadeh A, Karimi-Maleh H. Sequential determination of benserazide and levodopa by voltammetric method using chloranil as a mediator. J Braz Chem Soc.2010;21(8):1572-80.
5. Cesar IC, Bastos LF, Godin AM, Coelho M de M, Araujo DP, de Fatima A, et al. Simultaneous quantitation of nicorandil and its denitrated metabolite in plasma by LC-MS/MS: application for a pharmacokinetic study. J Mass Spectrom.2011;46(11):1125-30.
6. Lee ES, Chen H, King J, Charlton C. The role of 3-O-methyldopa in the side effects of L-dopa. Neurochem Res.2008;33(3):401-11.
7. Miller JW, Shukitt-Hale B, Villalobos-Molina R, Nadeau MR, Selhub J, Joseph JA. Effect of L-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats. Clin Neuropharmacol.1997;20(1):55-66.
8. Longhi JG, Perez E, Lima JJd, Cândido LMB. In vitro evaluation of Mucuna pruriens (L.) DC. antioxidant activity. Braz J Pharm Sci.2011;47(3):535-44.
9. César IC, Byrro RMD, Cardoso FFdSeS, Mundim IM, Teixeira LdS, Gomes SA, et al. Development and validation of a high-performance liquid chromatography– electrospray ionization–MS/MS method for the simultaneous quantitation of levodopa and carbidopa in human plasma. J Mass Spectrom.2011;46:943-8.
10. Lv L, Jiang W, Zhou S, Huang X, Shi X, Lv C, et al. LC–MS–MS Simultaneous Determination of L-Dopa and Its Prodrug L-Dopa n-Pentyl Ester Hydrochloride in Rat Plasma. Chromatographia.2010;72(3):239-43.
11. Jiang W, Lv L, Zhou S, Huang X, Shi X, Lv C, et al. Simultaneous determination of L-dopa and its prodrug (S)-4-(2-acetamido-3-ethoxy-3-oxopropyl)-1,2-phenylene diacetate in rat plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study. J Pharm Biomed Anal.2010;53(3):751-4.
12. Jonkers N, Sarre S, Ebinger G, Michotte Y. Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat. J Neural Transm.2001;108:559-70.
13. Karimi M, Carl JL, Loftin S, Perlmutter JS. Modified high-performance liquid chromatography with electrochemical detection method for plasma measurement of levodopa, 3-O-methyldopa, dopamine, carbidopa and 3,4-dihydroxyphenyl acetic acid. J Chromatogr B: Anal Technol Biomed Life Sci.2006;836(1-2):120-3.
14. Muzzi C, Bertocci E, Terzuoli L, Porcelli B, Ciari I, Pagani R, et al. Simultaneous determination of serum concentrations of levodopa, dopamine, 3-O-methyldopa and alpha-methyldopa by HPLC. Biomed Pharmacother.2008;62(4):253-8.
15. Tolokan A, Klebovich I, Balogh-Nemes K, Horvai G. Automated determination of levodopa and carbidopa in plasma by high-performance liquid chromatography-electrochemical detection using an on-line flow injection analysis sample pretreatment unit. J Chromatogr B: Biomed Sci Appl.1997;698(1-2):201-7.
16. Kim TH, Cho KH, Jung WS, Lee MS. Herbal Medicines for Parkinson’s Disease: A Systematic Review of Randomized Controlled Trials. PLoS ONE.2012;7(5):e35695.
17. Massano J, Garrett C. Deep brain stimulation and cognitive decline in Parkinson’s disease: a clinical review. Front Neurol.2012;3(66):1-13.
18. Pan L, Guo Y, Li Z, Chen J, Jiang T, Yu Y. Simultaneous Determination of Levodopa, Benserazide and 3-O-Methyldopa in Human Serum by LC–MS–MS. Chromatographia.2010;72(7):627-33.
19. Bedor DCG, Filho JHdS, Ramos VLS, Gonçalves TM, Sousa CEMd, Santana DPd. A sensitive and robust LC-MS/MS method with monolithic column and electrospray ionization for the quantitation of efavirenz in human plasma: application to a bioequivalence study. Quím Nova 2011;34(6):950-5.
20. Dalmora SL, Sangoi MdS, Nogueira DR, D’Avila FB, Moreno RA, Sverdloff CE, et al. Determination of phenobarbital in human plasma by a specific liquid chromatography method: application to a bioequivalence study. Quím Nova. 2010;33(1):124-9.
21. Igarashi K, Hotta K, Kasuya F, Abe K, Sakoda S. Determination of cabergoline and L-dopa in human plasma using liquid chromatography–tandem mass spectrometry. J Chromatogr B.2003;792:55-61.
22. Brasil. Agência Nacional de Vigilância Sanitária (ANVISA). Resolução RE nº 899, de 29 de maio de 2003.Aprova o Guia para validação de métodos analíticos e bioanalíticos. Diário Oficial da União Brasília (DF); 2 jun 2003; Seção 1
23. Brasil. Agência Nacional de Vigilância Sanitária (ANVISA). Resolução RDC nº 27, de 17 de maio de 2012. Dispõe sobre os requisitos mínimos para a validação de métodos bioanalíticos empregados em estudos com fins de registro e pós-registro de medicamentos. Diário Oficial da União, Brasília (DF); 22 mai 2012; seção 1
24. Saxer C, Niina M, Nakashima A, Nagae Y, Masuda N. Simultaneous determination of levodopa and 3-O-methyldopa in human plasma by liquid chromatography with electrochemical detection. J Chromatogr B: Analyt Technol Biomed Life Sci.2004;802(2):299-305.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2015 Instituto Adolfo Lutz Journal